Gov. Wes Moore made lowering drug costs a key campaign promise, making advocates of the law confident that their greatest ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli ...

A new study presented at the American Academy of Orthopedic Surgeons meeting reveals the need to stop taking GLP-1 agonists ...

New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed ...

Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.

Bacterial vaginosis affects nearly a third of women worldwide and can cause infertility, premature births and newborn deaths.

JD.com, Eli Lilly and Company, Abbott Laboratories, Veeva Systems, and Johnson & Johnson are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool.

“If I had a patch over my right eye it would be difficult to read,” said Sabellico, who is now managing his diabetes with the drug Trulicity and plans to take legal action. “The letters jump ...

Advt Eli Lilly's Trulicity (dulaglutide) was the most commonly used GLP-1 drug in the study. Some patients received Novo Nordisk's Ozempic (semaglutide) or the company's older Victoza (liraglutide).

Eli Lilly and Company’s LLY shares dipped almost 5% on Monday after rival Novo Nordisk NVO announced disappointing data from ...